What's New on the FDA Drugs Site
June 16, 2017
- Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recall of All Unexpired Nitroglycerin Injection In 5% Dextrose USP Products Produced At Its Houston Location From March 3, 2017 Through May 31, 2017 Due To Sub-Potency
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA updates on Pfizer drug shortages (updated)
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Dextrose 50% Injection (Updated - Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Hospira Issues a Voluntary Nationwide Recall For 8.4% Sodium Bicarbonate Injection, USP, Neuttm(Sodium Bicarbonate 4% Additive Solution), QUELICIN tm(Succinylcholine Chloride Injection, USP) and Potassium Phosphates Injection, USP Due To a Potential For Lack Of Sterility Assurance
- National Drug Code Directory
- Orange Book (updated)
- A special note for users of the Orange Book Express mobile app
- Orange Book Current Cumulative Supplement (PDF - 2.4MB)
- May 2017: Additions and Deletions to the Drug Product List (PDF - 375KB)
- Orange Book Data Files (compressed) (ZIP - 638KB)
- Reference Listed Drugs by ANDA Reference Standard List (PDF - 86KB)
- Orange Book Patent Listing Dispute List
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario